DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$78.55
-0.77 (-0.97%)
Performance
1D
—
1W
—
1M
—
3M
+87.78%
6M
+98.61%
1Y
+329.94%
YTD
+97.96%
Open$78.46
Previous Close$79.32
Day High$80.28
Day Low$76.42
52W High$88.02
52W Low$13.37
Volume—
Avg Volume1.88M
Market Cap3.56B
P/E Ratio—
EPS$-4.11
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.37
Above
SMA 200
$31.95
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-50.6% upside
Current
$78.55
$78.55
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.36M | 305.72M | 270.76M |
| Net Income | -188,403,262 | -32,339,215 | -26,813,974 |
| Profit Margin | -7,973.3% | -10.6% | -9.9% |
| EBITDA | -207,504,879 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |